S. Tisminetzky

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Sergio Gabriel Tisminetzky, Sergio G. Tisminetzky, S Tisminetzky, Sergio Tisminetzky, S.g. Tisminetzky, Sergio G Tisminetzky, S G Tisminetzky
Publication record
61 papers · 2,031 citations · H-index 22

PAPERS

A Simplified and Efficient Process for Insulin Production in Pichia pastoris
201638 citationsauthor #5
Dual Role of Dextran Sulfate 5000 Da as Anti-Apoptotic and Pro-Autophagy Agent
201311 citationsauthor #3
InTRONs in Biotech
201116 citationsauthor #3
Application of simple fed-batch technique to high-level secretory production of insulin precursor using Pichia pastoris with subsequent purification and conversion to human insulin
201095 citationsauthor #9
Improving human interferon‐β production in mammalian cell lines by insertion of an intronic sequence within its naturally uninterrupted gene
200914 citationsauthor #7
Improving human interferon-beta production in mammalian cell lines by insertion of an intronic seque
20091 citationsauthor #7
Long-term interferon therapy in patients with refractory chronic hepatitis C: effect on histological liver damage and hepatocellular carcinogenesis.
20080 citationsauthor #3
High‐level production and covalent immobilization of Providencia rettgeri penicillin G acylase (PAC) from recombinant Pichia pastoris for the development of a novel and stable biocatalyst of industrial applicability
200614 citationsauthor #8
TDP-43 Binds Heterogeneous Nuclear Ribonucleoprotein A/B through Its C-terminal Tail
2005463 citationsauthor #4
521 Lack of evidence of sexual transmission of hepatitis C among monogamous couples: Results of a ten-year prospective follow-up study
20044 citationsauthor #4
Lack of Evidence of Sexual Transmission of Hepatitis C among Monogamous Couples: Results of a 10-Year Prospective Follow-Up Study
2004340 citationsauthor #4
Expression and characterization of human interferon‐β1 in the methylotrophic yeast Pichia pastoris
200319 citationsauthor #4
Mix-infections with different genotypes of HCV and with HCV plus other hepatitis viruses in patients with hepatitis C in China.
200328 citationsauthor #7
Codelivery of DNA coding for the soluble form of CD86 results in the down-regulation of the immune response to DNA vaccines.
200118 citationsauthor #2
Oral transgene vaccination mediated by attenuated Salmonellae is an effective method to prevent Herpes simplex virus-2 induced disease in mice.
200144 citationsauthor #2
Cohort effect of HCV infection in liver cirrhosis assessed by a 25 year study.
200013 citationsauthor #4
Retreatment of chronic hepatitis C patients with previous non response to interferon alone
20004 citationsauthor #5
Superiority of intramuscular route and full length glycoprotein D for DNA vaccination against herpes simplex 2. Enhancement of protection by the co-delivery of the GM-CSF gene.
200030 citationsauthor #3
viral vaccines based on invasive bacteria.
20000 citationsauthor #3
Modulation of the immune response to DNA vaccine by co‐delivery ofcostimulatory molecules
200033 citationsauthor #2
Retreatment of chronic hepatitis C patients with interferonplusribavirin vs interferon alone
20003 citationsauthor #5
Influence of correct secondary and tertiary RNA folding on the binding of cellular factors to the HCV IRES.
200067 citationsauthor #2
IgM antibody response to the hepatitis C virus core protein in intravenous drug users.
19994 citationsauthor #5
Prediction of successful outcome in a randomised controlled trial of the long‐term efficacy of interferon alpha treatment for chronic hepatitis C
199914 citationsauthor #4
Immunoreactivity to Putative B-Cell Epitopes of Hepatitis G Virus Polyprotein in Viremic and Nonviremic Subjects
19994 citationsauthor #4
Factors associated with serum HCV RNA positivity in anti-HCV antibody positive intravenous drug users.
199812 citationsauthor #6
Interferon retreatment in patients with chronic hepatitis C
19984 citationsauthor #5
Natural β-interferon retreatment in chronic hepatitis C
19980 citationsauthor #4
The neutralizing antibody response against a conserved region of human immunodeficiency virus type 1 gp41 (amino acid residues 731-752) is uniquely directed against a conformational epitope.
199846 citationsauthor #3
Cohort effect of HCV infection in a cirrhotic population: a 25 years examination
19980 citationsauthor #4
Functional analysis of the interaction between HCV 5'UTR and putative subunits of eukaryotic translation initiation factor eIF3
1998126 citationsauthor #2
Localization of the different hepatitis C virus core gene products expressed in COS-1 cells.
19984 citationsauthor #3
High prevalence of infection with hepatitis G virus in patients with hepatic and extrahepatic malignancies.
19989 citationsauthor #7
Interferon versus ribavirin plus interferon in chronic hepatitis C patients relapsers and non responders to recombinant interferon
19982 citationsauthor #6
Endogenous Interferon-α Concentration and Outcome of Interferon Treatment in Patients with Chronic Hepatitis C
19978 citationsauthor #5
In vivo translational efficiency of different hepatitis C virus 5′‐UTRs
199742 citationsauthor #5
V3 loop core region serotyping of HIV-1 infected patients using the FHV epitope presenting system.
19978 citationsauthor #6
Endogenous interferon-alpha concentration and outcome of interferon treatment in patients with chronic hepatitis C.
19972 citationsauthor #5
Improved reactivity of hepatitis C virus core protein epitopes in a conformational antigen-presenting system
199719 citationsauthor #7
A neutralizing monoclonal antibody previously mapped exclusively on human immunodeficiency virus type 1 gp41 recognizes an epitope in p17 sharing the core sequence IEEE
199723 citationsauthor #2
Conformational display of two neutralizing epitopes of HIV-1 gp41 on the Flock House virus capsid protein.
199626 citationsauthor #2
Hepatitis C genotypes in patients with dual hepatitis B and C virus infection
199646 citationsauthor #7
Discordant results from hepatitis C virus genotyping by procedures based on amplification of different genomic regions
199616 citationsauthor #3
Distribution of three major hepatitis C virus genotypes in Italy. A multicentre study of 49 5 patients with chronic hepatitis C
199563 citationsauthor #4
Characterisation and chromosomal localisation of the rat α- and β-adducin-encoding genes
199516 citationsauthor #3
Comparison of genotyping and serotyping methods for the identification of hepatitis C virus types.
199521 citationsauthor #1
A new epitope presenting system displays a HIV-1 V3 loop sequence and induces neutralizing antibodies.
199528 citationsauthor #2
Characterisation and chromosomal localisation of the rat alpha- and beta-adducin-encoding genes.
19954 citationsauthor #3
Genomic organisation and chromosomal localisation of the gene encoding human beta adducin.
199519 citationsauthor #1
Hepatitis C virus genotypes HCV-1a and HCV-1b: the clinical point of view.
199518 citationsauthor #5
Genotypes of hepatitis C virus in Italian patients with chronic hepatitis C
199469 citationsauthor #1
Analysis of the hepatitis C virus genome in patients with anti-LKM-1 autoantibodies.
199433 citationsauthor #8
Outcome of Acute Hepatitis C and Role of Alpha Interferon Therapy
199423 citationsauthor #5
Immunoreactivity of chimeric proteins carrying the HIV‐1 epitope IGPGRAF Correlation between predicted conformation and antigenicity
199423 citationsauthor #1
230 Clinical features and response to interferon in patients with different HCV genotypes in Italy
19930 citationsauthor #3
Presence of a 43-kDa host-cell polypeptide in purified aphthovirions.
198810 citationsauthor #2
Molecular cloning of rotavirus genome.
19862 citationsauthor #3
Histone H3 modification in BHK cells infected with foot-and-mouth disease virus.
198430 citationsauthor #2
Heterogeneity of infection-associated particles in foot-and-mouth disease virus.
19813 citationsauthor #3
22 ANTIMENINGOCOCIQUE C. VACCINE EFFICACY
19810 citationsauthor #2
[Molecular biology of the foot-and-mouth disease virus].
19810 citationsauthor #4

TIMELINE

1981 3 citations

1984 30 citations

1986 2 citations

1988 10 citations

1993 0 citations

1994 148 citations

1995 169 citations

1996 88 citations

1997 102 citations

1998 203 citations

1999 22 citations

2000 150 citations

2001 62 citations

2003 47 citations

2004 344 citations

2005 463 citations

2006 14 citations

2008 0 citations

2009 15 citations

2010 95 citations

2011 16 citations

2013 11 citations

2016 38 citations

S. Tisminetzky

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT